|

dapagliflozin tablet Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Fontan Circulation1
  • Single Ventricle Heart Disease1
  • HFpEF - Heart Failure With Preserved Ejection Fraction1
  • Heart Disease1

Rochester, Minnesota1 trial

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.